![""](/research/sigurdsson-lab/sites/default/files/styles/fixed_height_250_1600w_320h/public/2023-01/sigurdsson-publications-hero.jpg?h=2c7ac911&itok=FJnAEs3D)
Sigurdsson Lab Publications
Investigators in the Sigurdsson Lab publish the results of their research in leading publications. Read the latest papers to learn more about our work.
Recent Publications
Single-domain antibody-based protein degrader for synucleinopathies
Molecular neurodegeneration. 2024 May 31; 19:44
Neuronal hypofunction and network dysfunction in a mouse model at an early stage of tauopathy
bioRxiv : the preprint server for biology. 2024 May 01;
Single-Domain Antibody-Based Protein Degrader for Synucleinopathies
bioRxiv : the preprint server for biology. 2024 Apr 30;
Tau Immunotherapies for Alzheimer's Disease and Related Tauopathies: Status of Trials and Insights from Preclinical Studies
Journal of Alzheimer's disease. 2024 Feb 26;
Tau-targeting therapies for Alzheimer disease: current status and future directions
Nature reviews. Neurology. 2023 Dec ; 19:715-736
Single-domain antibody-based noninvasive in vivo imaging of α-synuclein or tau pathology
Science advances. 2023 May 10; 9:eadf3775
Development of brain-penetrable antibody radioligands for in vivo PET imaging of amyloid-β and tau
Frontiers in nuclear medicine (Lausanne, Switzerland). 2023 Sep ; 3:
Amyloid-β targeting immunisation in aged non-human primate (Microcebus murinus).
Brain, behavior & immunity. 2022 Dec 30; 109:63-77